BiOasis Competitors

Pink Sheets . USA . 
Stock . biOasis Technologies
BIOAF Stock  USD 0.0001  0.00  0.00%   
biOasis Technologies competes with Covalon Technologies, Mosaic Immunoengineerin, Cellectis, Zenith Capital, and ProMIS Neurosciences; as well as few others. The company classifies itself under Biotechnology sector and is part of Health Care industry. Analyzing BiOasis Technologies competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of BiOasis Technologies to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out BiOasis Technologies Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of BiOasis Technologies competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.000.00010.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.0000840.00
Details
Naive
Forecast
LowNextHigh
0.00010.00010.0001
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00010.00010.0001
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as BiOasis Technologies. Your research has to be compared to or analyzed against BiOasis Technologies' peers to derive any actionable benefits. When done correctly, BiOasis Technologies' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in biOasis Technologies.

BiOasis Technologies Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between BiOasis Technologies and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of BiOasis and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of biOasis Technologies does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
BETRF
+ 0.66
PMN
BETRF
+ 0.47
BITRF
FENC
+ 0.43
PMN
CRPOF
+ 0.42
CVALF
BETRF
+ 0.39
CPMV
BETRF
+ 0.38
FENC
  
High negative correlations   
PMN
- 0.82
CRPOF
BETRF
- 0.58
CRPOF
FENC
- 0.54
CRPOF
BETRF
- 0.48
CVALF
PMN
- 0.39
CVALF
FENC
- 0.29
CVALF

Risk-Adjusted Indicators

There is a big difference between BiOasis Pink Sheet performing well and BiOasis Technologies Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze BiOasis Technologies' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
BITRF  3.09 (1.19) 0.00 (0.51) 0.00 
 0.00 
 1.34 
(5.84)
 62.53 
CVALF  2.01  0.14  0.02  0.48  2.21 
(2.57)
 6.67 
(4.48)
 12.66 
CPMV  6.67  0.91  0.04 (2.92) 9.20 
(16.60)
 25.71 
(25.58)
 81.86 
CRPOF  123.42  70.39  8.55 (0.99) 0.00 
(248.97)
 10.53 
(8.37)
 4,159 
CMVLF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
ZHCLF  25,444  15,650  187.75 (0.74) 95.75 
(55,113)
 900.00 
(98.56)
 700,000 
HOPHF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
PMN  3.40 (0.26) 0.00  0.42  0.00 
 0.00 
 6.25 
(7.48)
 27.19 
FENC  3.15  0.03  0.03  0.14  3.76 
(3.72)
 7.14 
(6.68)
 23.48 
BETRF  5.91  0.01 (0.01) 0.15  6.66 
(10.35)
 16.67 
(14.29)
 48.70 
All Fundamental Data

BiOasis Technologies Competitive Analysis

The better you understand BiOasis Technologies competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, BiOasis Technologies' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across BiOasis Technologies' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
BIOAF BITRF CVALF CPMV CRPOF CMVLF ZHCLF HOPHF PMN FENC
 0.00 
 0.0001 
BiOasis
 0.00 
 0.01 
Biotron
 5.65 
 2.62 
Covalon
 1.01 
 1.00 
Mosaic
 3.67 
 5.93 
Ceapro
 0.00 
 2.54 
Cellectis
 10.00 
 0.11 
Zenith
 0.00 
 0 
Hemogenyx
 2.17 
 0.94 
ProMIS
 0.83 
 6.06 
Fennec
Market Volatility
(90 Days Market Risk)
Very steady
Out of control
Risky
Out of control
Very steady
Very steady
Out of control
Very steady
Abnormally volatile
Slightly risky
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Modest
Modest
Very Weak
Very Weak
Solid
Very Weak
Very Weak
Insignificant
Odds of Financial Distress
(Probability Of Bankruptcy)
Very High
About Average
Low
High
Dangerous
Low
Low
Quite High
Very High
Very High
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Strong Buy
Strong Buy
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Not Rated
Strong Hold
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
0.38
2.35
10.04
0.07
18.65
3.17
0.17
20.23
5.42
5.12
Net Asset
2.27 M
1.91 M
30.38 M
269.49 K
30.53 M
382.08 M
2.88 M
8.52 M
18.04 M
26.86 M
Profit Margin
N/A
-1.78
-0.53
N/A
0.28
N/A
N/A
N/A
N/A
-0.023
EBITDA
(3.54 M)
(2.73 M)
(8.11 M)
(3.52 M)
4.65 M
(103.2 M)
(7.31 M)
(2.39 M)
(17.81 M)
(12.36 M)
Operating Margin
-11.41
-1.78
-0.5
N/A
0.32
-6.01
N/A
N/A
N/A
-0.75
Current Valuation
6 M
15.31 M
35.37 M
10.22 M
30.26 M
82.79 M
23.33 M
8.17 M
9.16 M
157.49 M
Price To Book
53.47
23.61
2.12
9.33
1.7
0.79
N/A
1.78
4.22
57.93
Retained Earnings
(18.69 M)
(37 M)
N/A
N/A
N/A
(206 M)
N/A
N/A
(123.84 M)
(219.25 M)
Current Asset
874 K
3 M
N/A
N/A
N/A
297 M
N/A
N/A
N/A
7.88 M
Beta
0.39
-1.2
1.19
-1.79
1.54
2.0
-187.63
3.49
0.61
0.27
Number Of Employees
23
10
24
3
10
294
4
10
6
29
Shares Outstanding
79.41 M
901.94 M
25.07 M
7.24 M
78.22 M
55.59 M
N/A
1.14 B
32.69 M
27.43 M
Cash Flow From Operations
(3.64 M)
(2.44 M)
(7.99 M)
(679.24 K)
3.51 M
(104.56 M)
(847 K)
(2.63 M)
(14.37 M)
(17.14 M)
Total Debt
401.76 K
77.24 K
2.25 M
735.15 K
2.51 M
18.77 M
3.94 M
10.15 K
13.07 M
30.95 M
Return On Equity
N/A
-1.12
-0.32
N/A
0.18
-0.56
N/A
-0.32
-10.99
-10.06
Z Score
-11.5
N/A
10.8
-38.1
9.0
4.2
-5.4
N/A
N/A
N/A
Return On Asset
-0.81
-0.56
-0.16
-4.2
0.11
-0.24
-1.6
-0.18
-4.81
0.027
Book Value Per Share
-0.034
0.002
0.96
-0.6
0.41
3.0
-0.1
0.007
0.2
-0.19
Number Of Shares Shorted
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
200.13 K
1.87 M
Current Liabilities
437 K
N/A
N/A
N/A
N/A
58 M
N/A
N/A
N/A
1.97 M
Total Asset
2.27 M
1.91 M
30.38 M
269.49 K
30.53 M
382.08 M
2.88 M
8.52 M
18.04 M
26.86 M
Debt To Equity
0.31
0.07
0.082
N/A
0.08
0.52
N/A
0.001
1.08
0.58
Target Price
0.58
N/A
N/A
N/A
N/A
N/A
N/A
N/A
12.22
13.6
Short Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
2.64
17.59
Shares Owned By Institutions
N/A
N/A
N/A
N/A
N/A
9.8
N/A
N/A
50.3
54.73
Market Capitalization
2.13 M
18.67 M
41.36 M
6.01 M
40.16 M
131.39 M
10.44 M
45.68 M
30.73 M
166.03 M
Price To Earning
13.82
-3.04
37.95
N/A
31.9
-13.64
N/A
N/A
N/A
-3.82
Price To Sales
26.52
11.17
2.3
N/A
1.89
4.79
N/A
N/A
5168.19
3.36
Net Income
(2.96 M)
(2.78 M)
(9.66 M)
(3.68 M)
2.84 M
(114.2 M)
(7.8 M)
(5.1 M)
(17.51 M)
(16.05 M)
Earnings Per Share
-0.031
-0.003
0.05
-0.51
0.05
-2.95
-0.059
-0.008
0.04
-0.04
Shares Owned By Insiders
2.05
14.13
56.6
88.73
3.92
N/A
N/A
13.01
44.78
16.22
Revenue
37.73 K
1.56 M
18.15 M
N/A
17.2 M
57.29 M
N/A
N/A
N/A
21.25 M
Working Capital
437 K
3 M
N/A
N/A
N/A
239 M
N/A
N/A
490.44 K
19.3 M
Cash And Equivalents
764.97 K
1.74 M
14.04 M
205.99 K
11.37 M
153.13 M
19 K
6.84 M
8.95 M
14.91 M
Cash Per Share
0.01
N/A
0.55
0.03
0.14
3.37
N/A
0.01
1.24
0.57
Gross Profit
(1.15 M)
1.56 M
7.49 M
N/A
9.69 M
34.18 M
N/A
N/A
(16.09 M)
1.45 M
Day Typical Price
1.0E-4
0.0125
2.63
0.93
5.83
2.54
0.11
0.0031
0.96
5.99
Accumulation Distribution
N/A
N/A
57.74
49.0
0.0523
N/A
N/A
N/A
1229.64
7468.77
Market Facilitation Index
N/A
N/A
0.0
8.0E-4
0.31
N/A
N/A
N/A
0.0
0.0
Daily Balance Of Power
0.0
0.0
4.666667
0.05
0.6774
0.0
9.2 T
0.0
0.3333
0.1613
Period Momentum Indicator
N/A
N/A
0.14
0.01
0.21
N/A
0.01
N/A
0.02
0.05
Rate Of Daily Change
1.0
1.0
1.06
1.01
1.04
1.0
1.1
1.0
1.02
1.01
Day Median Price
1.0E-4
0.0125
2.64
0.9
5.78
2.54
0.11
0.0031
0.97
5.96
Price Action Indicator
N/A
N/A
0.055
0.1
0.26
N/A
0.005
N/A
(0.02)
0.13
Relative Strength Index
N/A
63.34
75.33
55.08
59.79
N/A
54.22
N/A
50.29
41.8
Coefficient Of Variation
N/A
(996.94)
1377.85
1605.03
815.9
N/A
653.38
N/A
(1,307)
1694.76
Mean Deviation
N/A
3.09
2.01
6.67
123.42
N/A
25444.03
N/A
3.4
3.15
Jensen Alpha
N/A
(1.19)
0.1414
0.9111
70.39
N/A
15650.38
N/A
(0.26)
0.0287
Total Risk Alpha
N/A
(2.52)
(0.27)
(1.49)
(22.60)
N/A
(1,211)
N/A
(1.15)
(0.48)
Sortino Ratio
N/A
N/A
0.0248
0.0407
8.55
N/A
187.75
N/A
N/A
0.0296
Downside Variance
N/A
N/A
6.96
335.64
52.97
N/A
5054.83
N/A
N/A
15.78
Standard Deviation
N/A
9.39
2.8
14.17
509.09
N/A
87218.96
N/A
4.7
4.32
Kurtosis
N/A
31.69
0.7885
8.03
65.98
N/A
61.66
N/A
2.16
1.39
Potential Upside
N/A
1.34
6.67
25.71
10.53
N/A
900.0
N/A
6.25
7.14
Treynor Ratio
N/A
(0.51)
0.4774
(2.92)
(0.99)
N/A
(0.74)
N/A
0.4249
0.1445
Maximum Drawdown
N/A
62.53
12.66
81.86
4159.06
N/A
699999.8
N/A
27.19
23.48
Variance
N/A
88.26
7.83
200.81
259175.76
N/A
7.60714700093E9
N/A
22.06
18.7
Market Risk Adjusted Performance
N/A
(0.50)
0.4874
(2.91)
(0.98)
N/A
(0.73)
N/A
0.4349
0.1545
Risk Adjusted Performance
N/A
(0.07)
0.0627
0.0571
0.1037
N/A
0.127
N/A
(0.05)
0.0533
Skewness
N/A
(3.81)
0.5714
1.45
8.12
N/A
7.76
N/A
0.6762
0.2573
Semi Deviation
N/A
N/A
2.21
9.2
0.0
N/A
95.75
N/A
N/A
3.76
Information Ratio
N/A
(0.11)
0.0234
0.0526
0.1223
N/A
0.153
N/A
(0.11)
0.0272
Value At Risk
N/A
(5.84)
(4.48)
(25.58)
(8.37)
N/A
(98.56)
N/A
(7.48)
(6.68)
Expected Short fall
N/A
N/A
(2.57)
(16.60)
(248.97)
N/A
(55,113)
N/A
N/A
(3.72)
Downside Deviation
N/A
N/A
2.64
18.32
7.28
N/A
71.1
N/A
N/A
3.97
Semi Variance
N/A
N/A
4.87
84.66
(20.73)
N/A
9168.65
N/A
N/A
14.16

BiOasis Technologies Competition Performance Charts

Five steps to successful analysis of BiOasis Technologies Competition

BiOasis Technologies' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by biOasis Technologies in relation to its competition. BiOasis Technologies' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of BiOasis Technologies in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact BiOasis Technologies' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to biOasis Technologies, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your BiOasis Technologies position

In addition to having BiOasis Technologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Insurance Providers Thematic Idea Now

Insurance Providers
Insurance Providers Theme
Companies providing all types of insurance and insurance services. The Insurance Providers theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Insurance Providers Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in BiOasis Pink Sheet

BiOasis Technologies financial ratios help investors to determine whether BiOasis Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BiOasis with respect to the benefits of owning BiOasis Technologies security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY